Synonyms: Intron A® | intronA
IFN-α2b (recombinant human) is an approved drug (FDA (1986))
Compound class:
Peptide
Comment: The sequence of IFN-α2b, differs in only one residue from the sequence of the endogenous peptide, with Lys23 being replaced by Arg.
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects |
IFN-α2b activates interferon receptors to produce anti-viral, anti-proliferative, anti-tumor and immunomodulatory effects. |